AirDuo Digihaler, ArmonAir Digihaler Now Available for Asthma
The products contain a built-in electronic module that detects, records and stores data on inhaler events.
Asthma
Trelegy Ellipta Approved for Asthma Maintenance Treatment
Trelegy Ellipta combines fluticasone furoate, an inhaled corticosteroid with umeclidinium, an anticholinergic and vilanterol, a long-acting β2-adrenergic agonist.
AAP: Choosing Wisely Recs on Pediatric Pulmonology, Sleep Medicine
The list, titled “Five Things Physicians and Patients Should Question,” was developed by members of the AAP Section on Pediatric Pulmonology and Sleep Medicine.
FDA to Review Omalizumab Prefilled Syringe for Self-Administration
The FDA is expected to make a decision by the first quarter of 2021.
Dupilumab Improves Lung Function in CRSwNP and Comorbid Asthma and COPD Features
Treatment with dupilumab led to significant improvements in lung function by 16 weeks and up to 24 weeks in patients with chronic rhinosinusitis with nasal polyps and comorbid asthma plus clinical features of COPD.
Subclinical Bacteria in Home May Contribute to Poor Asthma Control
Subclinical bacteria in the home environment likely influence the airway microbiome and contribute to poor asthma control in patients with refractory asthma.
Benralizumab Improves Health-Related QoL Measures in Severe Eosinophilic Asthma
Patients with severe eosinophilic asthma who received benralizumab experienced significant improvements in several health-related quality of life measures.
Adolescents Who Use E-Cigarettes, Marijuana May Have Higher Odds of Lifetime Asthma
Electronic cigarette use is associated with lifetime asthma in US adolescents, and may become more damaging when combined with marijuana or cigarette smoking.
Telemedicine Program Improves Clinical Outcomes in Young Adults With Asthma
Young adults with asthma experienced improved clinical outcomes after undergoing virtual care, known as a multi-level EMR-integrated smartphone-telemedicine program.
ProAir Digihaler, a Rescue Inhaler With Built-In Sensors, Now Available
ProAir® Digihaler® (albuterol sulfate; Teva) Inhalation Powder is now available for patients aged ≥4 years for the treatment or prevention of bronchospasm with reversible obstructive airway disease, and for the prevention of exercise-induced bronchospasm (EIB).
